It is especially useful in conditions where oral supplementation is not suitable or effective, such as in critically ill patients, ICU cases, severe vomiting, or in patients with poor compliance to oral therapy
The dosage differences are significant too
doi: 10.3164/jcbn.15-146 37 LaaksoMKuusistoJ
Recalls & Warnings April 12, 2013 FDA Warns Consumers About The Dangers Of DMAA On April 11, 2013, the FDA warned consumers about the dangers of dietary supplements containing the ingredient 1,3-dimethylamylamine (DMAA)
Therefore, a comprehensive exploration and assessment should be performed to elucidate the relation behind each mechanism
These challenges present key opportunities for product development, positioning the sector as an important arena for technological advancement and economic growth (101)